AVR 1.67% $18.30 anteris technologies ltd

Aortic Vale publications form Berlin and Munich Hospitals, page-29

  1. 55 Posts.
    lightbulb Created with Sketch. 16
    Hi Reader
    thanks this is a valuable insight into the science. this is the kind of discussion i wanted to stimulate
    The only thing i would add is that these studies looked specifically at the adapt treated patches in aortic valve tissue in kids which from what i read are one of the best tests if a product is likely to calcify. Also the same results form 2 x independent centres suggest a pattern.
    I also dont think one off anectodal cases would be published in a series like this
    It would be good to re do the stats just for all the patients they have had the patch for aortic valve repair to see if there are more cases than this.
    Also i suppose we have to be careful with publications written by the inventor and the medical director of the company they could potentially be open to bias ?
    As been suggested no doubt this would be picked up by a big group doing DD and they would have the scientist to look at the big picture
    The big issue for me is , can this company claim 10 years with no calc on their ASX releases ?

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.30
Change
0.300(1.67%)
Mkt cap ! $351.7M
Open High Low Value Volume
$18.25 $18.30 $18.01 $12.33K 679

Buyers (Bids)

No. Vol. Price($)
1 300 $18.09
 

Sellers (Offers)

Price($) Vol. No.
$18.30 247 2
View Market Depth
Last trade - 14.56pm 04/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.